Kairos Pharma (KAPA) Cash From Investing

Annual CFI

N/A

December 1, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

KAPA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$0.00
KAPA annual cash flow from investing activities is currently at an all-time high

3-Year Low

-$109.00 K
KAPA annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
KAPA previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Feb 28, 2025
KAPA next annual earnings announcement is scheduled for Feb 28, 2025

OtherKAPAcash flowmetrics:

Annual CFF

-$425.00 K
KAPA annual cash flow from financing activities is -$425.00 thousand

Annual CFO

$81.00 K
KAPA annual cash flow from operations is $81.00 thousand

Annual FCF

$81.00 K
KAPA annual free cash flow is $81.00 thousand

Annual CAPEX

-
KAPA annual capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

KAPA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

KAPA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Kairos Pharma Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2021
-$109.00 K(<-9900.0%)
-
-
DateAnnualQuarterlyTTM
Dec 2020
$0.00
-
-

FAQ

  • What is the all time high annual CFI for Kairos Pharma?

What is the all time high annual CFI for Kairos Pharma?

Kairos Pharma all-time high annual cash flow from investing activities is $0.00